These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24853684)

  • 21. Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.
    Franco LAM; Moreira CHV; Buss LF; Oliveira LC; Martins RCR; Manuli ER; Lindoso JAL; Busch MP; Pereira AC; Sabino EC
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schistosoma mansoni co-infection modulates Chagas disease development but does not impair the effect of benznidazole-based chemotherapy.
    Lozano KJG; Gonçalves Santos E; Vilas Boas DF; Oliveira RRG; Diniz LF; Benedetti MD; Carneiro CM; C Bandeira L; Faria G; Gonçalves RV; Novaes RD; Caldas S; Caldas IS
    Int Immunopharmacol; 2024 Feb; 128():111467. PubMed ID: 38211479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host.
    Maya JD; Cassels BK; Iturriaga-Vásquez P; Ferreira J; Faúndez M; Galanti N; Ferreira A; Morello A
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):601-20. PubMed ID: 16626984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives.
    Maya JD; Bollo S; Nuñez-Vergara LJ; Squella JA; Repetto Y; Morello A; Périé J; Chauvière G
    Biochem Pharmacol; 2003 Mar; 65(6):999-1006. PubMed ID: 12623132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of action of the 2-nitroimidazole derivative benznidazole.
    Polak A; Richle R
    Ann Trop Med Parasitol; 1978 Feb; 72(1):45-54. PubMed ID: 418744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Antitrypanosomal Activity of 1,4-Disubstituted Triazole Compounds Based on a 2-Nitroimidazole Scaffold: a Structure-Activity Relationship Study.
    Assunção ELF; Carvalho DB; das Neves AR; Kawasoko Shiguemotto CY; Portapilla GB; de Albuquerque S; Baroni ACM
    ChemMedChem; 2020 Nov; 15(21):2019-2028. PubMed ID: 32729242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldo-keto reductase and alcohol dehydrogenase contribute to benznidazole natural resistance in Trypanosoma cruzi.
    González L; García-Huertas P; Triana-Chávez O; García GA; Murta SMF; Mejía-Jaramillo AM
    Mol Microbiol; 2017 Dec; 106(5):704-718. PubMed ID: 28884498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependent oxidative stress caused by benznidazole.
    Pedrosa RC; De Bem AF; Locatelli C; Pedrosa RC; Geremias R; Wilhelm Filho D
    Redox Rep; 2001; 6(4):265-70. PubMed ID: 11642718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyamine and thiol metabolism in Trypanosoma granulosum: similarities with Trypanosoma cruzi.
    Mastri C; Thorborn DE; Davies AJ; Ariyanayagam MR; Hunter KJ
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1177-82. PubMed ID: 11302739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrinsic and Chemotherapeutic Stressors Modulate ABCC-Like Transport in
    da Costa KM; Salustiano EJ; Valente RDC; Freire-de-Lima L; Mendonça-Previato L; Previato JO
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207619
    [No Abstract]   [Full Text] [Related]  

  • 31. Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi.
    Vázquez C; Mejia-Tlachi M; González-Chávez Z; Silva A; Rodríguez-Zavala JS; Moreno-Sánchez R; Saavedra E
    FEBS Lett; 2017 Dec; 591(23):3881-3894. PubMed ID: 29127710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease.
    Kratz JM; Garcia Bournissen F; Forsyth CJ; Sosa-Estani S
    Expert Rev Clin Pharmacol; 2018 Oct; 11(10):943-957. PubMed ID: 30111183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic Control Analysis for Drug Target Prioritization in Trypanosomatids.
    González-Chávez Z; Vázquez C; Moreno-Sánchez R; Saavedra E
    Methods Mol Biol; 2020; 2116():689-718. PubMed ID: 32221950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key proteins in the polyamine-trypanothione pathway as drug targets against Trypanosoma cruzi.
    Maya JD; Salas CO; Aguilera-Venegas B; Diaz MV; López-Muñoz R
    Curr Med Chem; 2014; 21(15):1757-71. PubMed ID: 24251576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
    Adeyemi OS; Molina MT; Eseola AO; Fonseca-Berzal C; Gómez-Barrio A
    Comb Chem High Throughput Screen; 2017; 20(1):20-24. PubMed ID: 28071587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.
    Mesías AC; Sasoni N; Arias DG; Pérez Brandán C; Orban OCF; Kunick C; Robello C; Comini MA; Garg NJ; Zago MP
    Free Radic Biol Med; 2019 Jan; 130():23-34. PubMed ID: 30359758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi.
    Maya JD; Repetto Y; Agosín M; Ojeda JM; Tellez R; Gaule C; Morello A
    Mol Biochem Parasitol; 1997 May; 86(1):101-6. PubMed ID: 9178272
    [No Abstract]   [Full Text] [Related]  

  • 38. Automated high-content assay for compounds selectively toxic to Trypanosoma cruzi in a myoblastic cell line.
    Alonso-Padilla J; Cotillo I; Presa JL; Cantizani J; Peña I; Bardera AI; Martín JJ; Rodriguez A
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003493. PubMed ID: 25615687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantum mechanical, molecular docking, molecular dynamics, ADMET and antiproliferative activity on
    Geysillene Castro Matos M; da Silva LP; Wagner Queiroz Almeida-Neto F; Machado Marinho E; Róseo Paula Pessoa Bezerra de Menezes R; Lima Sampaio T; Nunes da Rocha M; Rodrigues Ribeiro L; Paula Magalhaes E; Rodrigues Teixeira AM; Dos Santos HS; Marinho ES; de Lima-Neto P; Costa Martins AM; Monteiro NKV; Machado Marinho M
    Phys Chem Chem Phys; 2022 Feb; 24(8):5052-5069. PubMed ID: 35144275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic analysis of Trypanosoma cruzi resistance to Benznidazole.
    Andrade HM; Murta SM; Chapeaurouge A; Perales J; Nirdé P; Romanha AJ
    J Proteome Res; 2008 Jun; 7(6):2357-67. PubMed ID: 18435557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.